Preliminary Results of PROCLAIM-CX-072: The First-in-Human, Dose-Finding Trial of PD-L1 Probody Therapeutic CX-072 as Monotherapy in Patients With Advanced Solid Tumors

Valentina Boni, Javier Garcia-Corbacho, Patrick A. Ott, Daniel Cho, Karen A. Autio, Nataliya Uboha, Alexander I. Spira, Rachel Humphrey, Matthias Will, Aung Naing, Fiona Thistlethwaite, Elisabeth de Vries, Hendrik-Tobias Arkenau. Poster presented at ESMO 2018, October 19-23, Munich, Germany.